Lars Örning

Title: The Innovations of Lars Örning in the Field of Assay Methods

Introduction

Lars Örning, an accomplished inventor based in Oslo, Norway, has made significant contributions to the field of biochemistry and clinical assays with a portfolio of five patents. His innovative work focuses primarily on assay methods related to transcobalamin and cobalamin, critical components in Vitamin B12 metabolism.

Latest Patents

Among Lars Örning's recent patents, the "Transcobalamin II Assay Method" stands out. This novel method involves determining transcobalamin saturation by contacting a transcobalamin-containing liquid sample with a porous substrate that has an immobilized transcobalamin-binding ligand. This substrate is then interacted with a reporter-labeled transcobalamin-binding partner, allowing for the detection of signals from the reporter labels that become immobilized on the substrate. A unique feature of this method is that one of either the ligand or the binding partner can specifically bind to either holo transcobalamin or apo transcobalamin, enhancing the assay's specificity and reliability.

Another significant patent is the "Cobalamin Assay," which introduces a specific binding partner for holoTC that exhibits a specificity over apoTC of at least 40-fold. This assay method involves contacting a sample with the specific binding partner for holoTC and detecting the resultant conjugates, facilitating precise measurement of holo transcobalamin levels in various samples.

Career Highlights

Currently, Lars Örning is associated with Axis-Shield ASA, where he applies his expertise to the development of innovative diagnostic solutions. His work focuses on advancing the understanding and measurement of biochemicals critical for health assessments.

Collaborations

Lars collaborates with renowned professionals such as Anne Rian and Erling Sundrehagen, who contribute diverse perspectives and skills to the innovative projects at Axis-Shield ASA. This collaboration enhances the research environment and fosters the development of new technologies in the assay and diagnostics field.

Conclusion

Lars Örning's contributions to patenting methods for assay technologies exemplify the impact that innovative inventors have on the scientific community. With his latest patents pushing the boundaries of assay capabilities, he continues to play a pivotal role in advancing biomedical research and diagnostics. His work, in partnership with skilled colleagues, promises to drive further innovations in the field.